Events › B2B Event
B2B Event
3rd edition
The 3rd Annual Personalized Cancer Vaccine Summit (2026) is a specialized conference focusing on the scientific, operational, and regulatory challenges of developing personalized cancer vaccines, covering mRNA, peptide, viral vector, and dendritic cell platforms.
Exhibitor mix: Sponsors typically categorized as CMC/Manufacturing, CDMOs, Analytics/Platform Technology, or Regulatory Advisory partners.
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To hear data-driven case studies on PCV development, network with peers in CMC/Clinical/Translational roles, and find partners to solve scaling and manufacturing bottlenecks.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
30 speakers at Personalized Cancer Vaccine Summit
SVP Global Regulatory Affairs · BioNTech
"From Bioinformatics to the Bedside: Verifying Neoantigens & Tracking Vaccine Response Through Blood-Based Immune Analytics"
"Manufacturing of an Individualized Cancer Vaccine based on Modified Vaccinia Ankara (MVA) Viral Platform"
Twist Bioscience
"Exploring New Worlds in mRNA: The Next Generation of Discovery and Design"
"Leveraging Immunopeptidomics to Validate Endogenous Antigen Presentation & De-Risk Epitope Selection"
Also speaking at Programmatic I/O New York 2026, AdExchanger Awards 2026
"Using ctDNA & Immune Biomarkers to Capture Dynamic Tumor Biology, Monitor Treatment Response, & Guide Smarter Vaccine Design"
NEC Bio
"Advancing Personalized Cancer Vaccines Through AI-Driven Antigen Prediction & Clinical Translation"
Travis Yates Seminars
"Personalis NeXT Platform: Precision Neoantigen Selection & MRD Detection"
Head of Scientific Platforms & Strategy · Eclipsebio
"Ensuring RNA Quality: Sequencing-Based Validation for Manufacturing Success"
Also speaking at 6th mRNA-Based Therapeutics Summit
+ 14 more speakers at this event.
More events in United States
Frequently asked questions